BEXAROTENE

BEXAROTENE was reported 1325 times

BEXAROTENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS T-CELL LYMPHOMA REFRACTORY 7 0.3333
1 CUTANEOUS T-CELL LYMPHOMA STAGE I 9 0.2500
2 SEZARY CELLS INCREASED 2 0.2500
3 THYROID STIMULATING HORMONE DEFICIENCY 8 0.2424
4 REGIONAL CHEMOTHERAPY 1 0.1667
5 MYCOSIS FUNGOIDES REFRACTORY 1 0.1667
6 CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS 1 0.1250
7 CUTANEOUS T-CELL LYMPHOMA RECURRENT 7 0.1111
8 CUTANEOUS T-CELL LYMPHOMA STAGE II 2 0.0909
9 CUTANEOUS T-CELL LYMPHOMA STAGE IV 3 0.0833
10 HYPO HDL CHOLESTEROLAEMIA 1 0.0769
11 MYCOSIS FUNGOIDES RECURRENT 2 0.0690
12 PSEUDO LYMPHOMA 2 0.0571
13 MYCOSIS FUNGOIDES STAGE II 1 0.0435
14 DIPHTHERIA 2 0.0426
15 PYELECTASIA 1 0.0370
16 MYCOSIS FUNGOIDES 30 0.0365
17 SUPERINFECTION FUNGAL 3 0.0353
18 SECONDARY HYPOTHYROIDISM 5 0.0327
19 GOODPASTURE'S SYNDROME 1 0.0294
20 GALLBLADDER FISTULA 1 0.0294
21 APPLICATION SITE FISSURE 2 0.0222
22 CUTANEOUS T-CELL LYMPHOMA 27 0.0214
23 BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL 1 0.0185
24 STAPHYLOCOCCAL IMPETIGO 1 0.0175
25 LICHEN MYXOEDEMATOSUS 1 0.0169
26 APPLICATION SITE CELLULITIS 1 0.0149
27 HYPERVITAMINOSIS 2 0.0145
28 PARESIS CRANIAL NERVE 1 0.0143
29 SCLEREMA 1 0.0123
30 CENTRAL HYPOTHYROIDISM 4 0.0121
31 RETINOIC ACID SYNDROME 2 0.0116
32 ELDERLY 1 0.0112
33 HYPERTRIGLYCERIDAEMIA 59 0.0101
34 POST INFLAMMATORY PIGMENTATION CHANGE 4 0.0088
35 CHOLURIA 3 0.0088
36 ANEURYSM REPAIR 1 0.0088
37 LICHEN PLANOPILARIS 1 0.0085
38 DACRYOCANALICULITIS 1 0.0085
39 ACHROMOBACTER INFECTION 1 0.0083
40 PALMOPLANTAR KERATODERMA 6 0.0083
41 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
42 T-CELL LYMPHOMA 9 0.0079
43 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
44 LIPIDS ABNORMAL 5 0.0069
45 SYMPTOM MASKED 5 0.0069
46 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 2 0.0068
47 IMMUNOLOGY TEST ABNORMAL 1 0.0064
48 MONONEURITIS 1 0.0064
49 INTERNATIONAL NORMALISED RATIO 1 0.0062
50 HYPOHIDROSIS 3 0.0060
51 HAEMOCONCENTRATION 1 0.0058
52 ALOPECIA SCARRING 1 0.0055
53 ACANTHOSIS NIGRICANS 1 0.0054
54 NEUTROPHILIC DERMATOSIS 2 0.0051
55 CUTANEOUS LYMPHOMA 1 0.0049
56 GLOMERULONEPHRITIS ACUTE 1 0.0049
57 PRODUCT INTOLERANCE 1 0.0045
58 EPIDERMOLYSIS 2 0.0043
59 DYSLIPIDAEMIA 22 0.0043
60 CANCER FATIGUE 1 0.0042
61 BIOPSY SKIN ABNORMAL 1 0.0042
62 TELANGIECTASIA 4 0.0041
63 HODGKIN'S DISEASE 3 0.0041
64 DRUG-DISEASE INTERACTION 3 0.0041
65 LATEX ALLERGY 1 0.0041
66 APPLICATION SITE INFECTION 2 0.0039
67 CONJUNCTIVITIS VIRAL 1 0.0038
68 THYROID HORMONES DECREASED 3 0.0037
69 HYPEREOSINOPHILIC SYNDROME 2 0.0037
70 PSEUDOLYMPHOMA 2 0.0036
71 CELLULITIS ORBITAL 2 0.0034
72 BACTERIAL TEST 1 0.0034
73 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
74 THYROXINE DECREASED 2 0.0032
75 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
76 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
77 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
78 BRAIN MASS 1 0.0030
79 PNEUMONIA ESCHERICHIA 1 0.0029
80 DERMATITIS PSORIASIFORM 6 0.0029
81 PNEUMONITIS CHEMICAL 1 0.0029
82 LYMPHOMA TRANSFORMATION 1 0.0028
83 VISCERAL LEISHMANIASIS 2 0.0028
84 MILIA 1 0.0028
85 CHOROIDITIS 1 0.0027
86 SKIN DISCHARGE 1 0.0026
87 GENITAL ULCERATION 2 0.0026
88 COAGULATION TEST ABNORMAL 2 0.0026
89 GALLBLADDER PERFORATION 1 0.0026
90 CEREBELLAR STROKE 1 0.0026
91 ASEPTIC NECROSIS BONE 2 0.0026
92 SUPERINFECTION BACTERIAL 2 0.0025
93 STICKY SKIN 1 0.0025
94 DELIRIUM TREMENS 1 0.0025
95 LIPIDS INCREASED 5 0.0025
96 ARTERIAL THROMBOSIS LIMB 1 0.0024
97 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
98 HYPOTHYROIDISM 75 0.0023
99 RETICULOCYTE COUNT DECREASED 1 0.0023
100 VENOUS THROMBOSIS 9 0.0023
101 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
102 VITILIGO 5 0.0021
103 DIFFUSE LARGE B-CELL LYMPHOMA 16 0.0021
104 EXERCISE LACK OF 1 0.0021
105 EPIDERMAL NECROSIS 2 0.0021
106 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
107 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
108 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
109 METASTASES TO BONE MARROW 1 0.0020
110 EXPOSURE VIA PARTNER 1 0.0020
111 LYMPHOCYTIC INFILTRATION 2 0.0020
112 PYODERMA 1 0.0020
113 CAPILLARY LEAK SYNDROME 4 0.0019
114 HYPERLIPASAEMIA 1 0.0019
115 NAIL RIDGING 1 0.0019
116 TUMOUR NECROSIS 2 0.0019
117 HYPERMETABOLISM 1 0.0019
118 INTERTRIGO 1 0.0018
119 INTERLEUKIN LEVEL INCREASED 1 0.0018
120 RENAL STONE REMOVAL 1 0.0018
121 CATHETER SITE INFLAMMATION 1 0.0018
122 MEDICAL DEVICE SITE PAIN 1 0.0018
123 OPHTHALMIC HERPES SIMPLEX 1 0.0017
124 APPLICATION SITE DISCHARGE 2 0.0017
125 PROCALCITONIN INCREASED 2 0.0017
126 FACIAL PARESIS 6 0.0017
127 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 1 0.0017
128 PITTING OEDEMA 1 0.0016
129 PARACENTESIS 1 0.0016
130 XEROSIS 2 0.0016
131 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
132 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
133 APPLICATION SITE WARMTH 2 0.0016
134 PAROTID GLAND ENLARGEMENT 1 0.0015
135 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
136 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
137 CHOREOATHETOSIS 1 0.0015
138 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
139 LEG AMPUTATION 6 0.0015
140 CEREBRAL CYST 1 0.0015
141 APPLICATION SITE INFLAMMATION 2 0.0014
142 LEIOMYOMA 1 0.0014
143 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
144 FUSARIUM INFECTION 1 0.0014
145 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
146 APPLICATION SITE ULCER 1 0.0014
147 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
148 LYMPHOPROLIFERATIVE DISORDER 4 0.0014
149 SMALL FIBRE NEUROPATHY 1 0.0014
150 MYOGLOBIN BLOOD INCREASED 2 0.0013
151 PULMONARY ARTERY THROMBOSIS 1 0.0013
152 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
153 PNEUMONIA MYCOPLASMAL 1 0.0013
154 URINARY HESITATION 3 0.0013
155 EROSIVE DUODENITIS 1 0.0013
156 SINUSITIS FUNGAL 1 0.0012
157 HERPES ZOSTER DISSEMINATED 1 0.0012
158 SKIN BACTERIAL INFECTION 1 0.0012
159 SKIN EROSION 4 0.0012
160 APPLICATION SITE DISCOLOURATION 5 0.0012
161 RECALL PHENOMENON 1 0.0012
162 GRANULOMA 4 0.0012
163 AXONAL NEUROPATHY 1 0.0011
164 ALOPECIA AREATA 2 0.0011
165 HYPERCHOLESTEROLAEMIA 11 0.0011
166 SKIN HYPOPIGMENTATION 2 0.0011
167 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
168 ANOGENITAL WARTS 1 0.0011
169 CERUMEN IMPACTION 1 0.0011
170 MUSCLE SWELLING 1 0.0011
171 SKIN GRAFT 1 0.0011
172 APPLICATION SITE DERMATITIS 1 0.0011
173 PNEUMONIA CRYPTOCOCCAL 1 0.0011
174 BRAIN STEM HAEMORRHAGE 1 0.0011
175 CEREBRAL PALSY 1 0.0011
176 CEREBELLAR ATAXIA 1 0.0010
177 CANCER SURGERY 1 0.0010
178 HEPATIC CYTOLYSIS 13 0.0010
179 OCCULT BLOOD POSITIVE 2 0.0010
180 PRINZMETAL ANGINA 1 0.0010
181 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
182 DERMATITIS EXFOLIATIVE 5 0.0010
183 DEVICE RELATED SEPSIS 2 0.0010
184 HYPOGONADISM 1 0.0010
185 ALVEOLITIS ALLERGIC 1 0.0010
186 SKIN NECROSIS 5 0.0010
187 SKIN PLAQUE 8 0.0009
188 CD4 LYMPHOCYTES DECREASED 2 0.0009
189 AORTIC DILATATION 1 0.0009
190 APPLICATION SITE DRYNESS 3 0.0009
191 CEREBRAL VENTRICLE DILATATION 1 0.0009
192 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
193 HYPERLIPIDAEMIA 10 0.0008
194 PYODERMA GANGRENOSUM 3 0.0008
195 HEPATITIS CHOLESTATIC 5 0.0008
196 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
197 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
198 ORAL MUCOSA EROSION 1 0.0008
199 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
200 HYPERNATRAEMIA 4 0.0008
201 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
202 ABORTION MISSED 1 0.0008
203 NOCTURNAL DYSPNOEA 1 0.0008
204 APPLICATION SITE EROSION 1 0.0008
205 POLYARTHRITIS 4 0.0008
206 HERPES OPHTHALMIC 1 0.0008
207 ADRENAL INSUFFICIENCY 9 0.0007
208 SKIN DEPIGMENTATION 1 0.0007
209 BILIARY TRACT DISORDER 1 0.0007
210 H1N1 INFLUENZA 1 0.0007
211 INTESTINAL FISTULA 1 0.0007
212 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
213 CEREBELLAR HAEMORRHAGE 1 0.0007
214 MENINGITIS BACTERIAL 1 0.0007
215 EXCESSIVE EYE BLINKING 1 0.0007
216 STEROID DIABETES 1 0.0007
217 GENITAL HERPES 1 0.0007
218 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
219 NEOPLASM SKIN 1 0.0006
220 SKIN INFECTION 7 0.0006
221 ANGINA UNSTABLE 4 0.0006
222 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
223 THERAPY CHANGE 6 0.0006
224 METABOLIC SYNDROME 1 0.0006
225 PAPILLOMA VIRAL INFECTION 1 0.0006
226 COLONIC POLYP 1 0.0006
227 SKIN MASS 4 0.0006
228 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
229 SKIN LESION 16 0.0006
230 ACUTE SINUSITIS 1 0.0006
231 BLOOD CHLORIDE INCREASED 1 0.0006
232 HYPOPITUITARISM 1 0.0006
233 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
234 LYMPHOPENIA 8 0.0006
235 JUGULAR VEIN THROMBOSIS 1 0.0006
236 SKIN WEEPING 2 0.0006
237 BLOOD CHOLESTEROL INCREASED 26 0.0006
238 OESOPHAGEAL SPASM 1 0.0005
239 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
240 LOBAR PNEUMONIA 1 0.0005
241 SMALL INTESTINAL PERFORATION 1 0.0005
242 NARCOLEPSY 1 0.0005
243 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
244 INFECTED SKIN ULCER 1 0.0005
245 SEPTIC SHOCK 23 0.0005
246 BONE MARROW TRANSPLANT 1 0.0005
247 BILE DUCT OBSTRUCTION 1 0.0005
248 PARANASAL SINUS HYPERSECRETION 2 0.0005
249 HYPOALBUMINAEMIA 4 0.0005
250 ATROPHY 1 0.0005
251 PURULENCE 1 0.0005
252 BICYTOPENIA 1 0.0005
253 MULTI-ORGAN DISORDER 1 0.0005
254 DRUG ERUPTION 9 0.0005
255 OESOPHAGEAL CANDIDIASIS 2 0.0005
256 APPLICATION SITE PAIN 11 0.0005
257 SUDDEN HEARING LOSS 1 0.0005
258 EAR HAEMORRHAGE 1 0.0005
259 DISEASE PROGRESSION 58 0.0005
260 APPLICATION SITE IRRITATION 6 0.0005
261 BODY TEMPERATURE FLUCTUATION 1 0.0005
262 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
263 ANAEMIA MACROCYTIC 1 0.0005
264 RADIATION PNEUMONITIS 1 0.0005
265 LYMPHOCYTOSIS 1 0.0005
266 FACIAL PALSY 1 0.0005
267 TUMOUR LYSIS SYNDROME 4 0.0005
268 THYROID DISORDER 7 0.0005
269 LYMPHOMA 7 0.0005
270 FAECES PALE 1 0.0004
271 RHINITIS ALLERGIC 2 0.0004
272 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
273 THERAPY PARTIAL RESPONDER 7 0.0004
274 ADENOCARCINOMA 1 0.0004
275 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
276 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
277 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
278 METASTASES TO MENINGES 1 0.0004
279 LICHENOID KERATOSIS 1 0.0004
280 PANCREATITIS NECROTISING 1 0.0004
281 APHTHOUS STOMATITIS 1 0.0004
282 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
283 PAPULE 3 0.0004
284 PUSTULE 1 0.0004
285 EOSINOPHIL COUNT DECREASED 1 0.0004
286 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
287 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
288 SINUS OPERATION 1 0.0004
289 APPLICATION SITE ERYTHEMA 11 0.0004
290 GRAFT VERSUS HOST DISEASE 3 0.0004
291 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
292 RASH PUSTULAR 3 0.0004
293 HAEMATOLOGICAL INFECTION 1 0.0004
294 GLOMERULONEPHRITIS 1 0.0004
295 APPLICATION SITE BURN 2 0.0004
296 STAPHYLOCOCCAL SEPSIS 2 0.0004
297 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
298 APPLICATION SITE SWELLING 2 0.0004
299 ERYSIPELAS 2 0.0004
300 TOXIC SKIN ERUPTION 4 0.0004
301 LYMPHADENOPATHY 14 0.0004
302 DERMATOMYOSITIS 1 0.0004
303 CHEMICAL BURN OF SKIN 1 0.0004
304 APPENDICITIS PERFORATED 1 0.0004
305 HAEMORRHAGE URINARY TRACT 1 0.0004
306 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
307 HYPERBILIRUBINAEMIA 4 0.0004
308 ACTINIC KERATOSIS 1 0.0004
309 FAILURE TO THRIVE 2 0.0004
310 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
311 FOLLICULITIS 4 0.0004
312 EXFOLIATIVE RASH 1 0.0004
313 LUNG OPACITY 1 0.0004
314 SERUM FERRITIN INCREASED 2 0.0004
315 PROTEIN TOTAL INCREASED 1 0.0004
316 LIP BLISTER 1 0.0004
317 BLOOD PHOSPHORUS INCREASED 1 0.0004
318 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
319 SECOND PRIMARY MALIGNANCY 3 0.0004
320 CHOLECYSTITIS INFECTIVE 1 0.0004
321 TRANSAMINASES INCREASED 8 0.0004
322 SKIN FISSURES 7 0.0004
323 PRODUCT LEAKAGE 2 0.0004
324 PSYCHOMOTOR RETARDATION 1 0.0004
325 HEPATOCELLULAR INJURY 5 0.0004
326 GENERALISED ERYTHEMA 2 0.0004
327 SCAB 4 0.0004
328 FIBULA FRACTURE 1 0.0003
329 PARAPLEGIA 1 0.0003
330 EYELID MARGIN CRUSTING 1 0.0003
331 GASTROINTESTINAL NECROSIS 1 0.0003
332 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
333 IMMUNOSUPPRESSION 3 0.0003
334 SYMPTOM RECURRENCE 2 0.0003
335 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
336 EMERGENCY CARE 1 0.0003
337 INSURANCE ISSUE 5 0.0003
338 SMALL INTESTINAL OBSTRUCTION 4 0.0003
339 ERYTHEMA MULTIFORME 3 0.0003
340 BLOOD CREATININE DECREASED 1 0.0003
341 HAEMATOTOXICITY 3 0.0003
342 ORTHOPNOEA 1 0.0003
343 PORTAL VEIN THROMBOSIS 1 0.0003
344 APPLICATION SITE PRURITUS 7 0.0003
345 APPLICATION SITE VESICLES 2 0.0003
346 POSTURE ABNORMAL 1 0.0003
347 HYPOGAMMAGLOBULINAEMIA 2 0.0003
348 INABILITY TO AFFORD MEDICATION 3 0.0003
349 NEPHRITIS 1 0.0003
350 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
351 NEOPLASM RECURRENCE 1 0.0003
352 B-CELL LYMPHOMA 1 0.0003
353 LEFT VENTRICULAR FAILURE 1 0.0003
354 PRIAPISM 1 0.0003
355 EOSINOPHILIA 5 0.0003
356 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
357 RENAL FAILURE ACUTE 12 0.0003
358 FIBRIN D DIMER INCREASED 1 0.0003
359 CONJUNCTIVAL HYPERAEMIA 1 0.0003
360 RENAL TRANSPLANT 1 0.0003
361 PRODUCT PRESCRIBING ISSUE 6 0.0003
362 STAPHYLOCOCCAL INFECTION 9 0.0003
363 THERAPY CESSATION 14 0.0003
364 SKIN ULCER 7 0.0003
365 HEPATIC FUNCTION ABNORMAL 10 0.0003
366 CHEMOTHERAPY 1 0.0003
367 GINGIVAL DISORDER 1 0.0003
368 ACUTE RESPIRATORY FAILURE 5 0.0003
369 LUNG INFECTION 4 0.0003
370 MULTIPLE ALLERGIES 2 0.0003
371 PNEUMONIA FUNGAL 1 0.0003
372 FURUNCLE 2 0.0003
373 HYPERPHAGIA 1 0.0003
374 ATRIAL FLUTTER 2 0.0003
375 BLEPHARITIS 1 0.0002
376 SKIN EXFOLIATION 21 0.0002
377 HOMICIDAL IDEATION 1 0.0002
378 NO THERAPEUTIC RESPONSE 3 0.0002
379 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
380 RECURRENT CANCER 1 0.0002
381 HYPERURICAEMIA 1 0.0002
382 ANAPHYLACTOID REACTION 1 0.0002
383 HYPERCALCAEMIA 3 0.0002
384 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
385 ACUTE CORONARY SYNDROME 2 0.0002
386 CYTOMEGALOVIRUS INFECTION 4 0.0002
387 PNEUMONIA ASPIRATION 6 0.0002
388 COAGULOPATHY 4 0.0002
389 CONGESTIVE CARDIOMYOPATHY 1 0.0002
390 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
391 FACE OEDEMA 4 0.0002
392 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
393 HEPATIC PAIN 1 0.0002
394 LUNG NEOPLASM 1 0.0002
395 PURULENT DISCHARGE 1 0.0002
396 SHOULDER OPERATION 1 0.0002
397 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
398 SKIN HYPERPIGMENTATION 2 0.0002
399 CARDIAC OPERATION 2 0.0002
400 MONOPLEGIA 1 0.0002
401 MELANOCYTIC NAEVUS 1 0.0002
402 GASTRITIS 6 0.0002
403 LUNG INFILTRATION 2 0.0002
404 BRAIN NEOPLASM MALIGNANT 1 0.0002
405 IRON DEFICIENCY 1 0.0002
406 LEUKOCYTOSIS 4 0.0002
407 PATHOGEN RESISTANCE 2 0.0002
408 HAEMOGLOBIN INCREASED 1 0.0002
409 PNEUMONIA BACTERIAL 2 0.0002
410 PRODUCT DISTRIBUTION ISSUE 2 0.0002
411 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
412 FEELING OF DESPAIR 1 0.0002
413 PERFORMANCE STATUS DECREASED 1 0.0002
414 FLANK PAIN 2 0.0002
415 SKIN TIGHTNESS 1 0.0002
416 SQUAMOUS CELL CARCINOMA 2 0.0002
417 CARDIAC FAILURE 17 0.0002
418 ECZEMA 11 0.0002
419 SUBCUTANEOUS ABSCESS 1 0.0002
420 FAECAL INCONTINENCE 1 0.0002
421 APHAGIA 1 0.0002
422 HYPERTHYROIDISM 3 0.0002
423 TREATMENT FAILURE 17 0.0002
424 HORMONE LEVEL ABNORMAL 1 0.0002
425 INCORRECT DOSAGE ADMINISTERED 1 0.0002
426 PANCREATIC DISORDER 1 0.0002
427 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
428 HOSPICE CARE 2 0.0002
429 SKIN HAEMORRHAGE 3 0.0002
430 FOOT OPERATION 1 0.0002
431 ANEURYSM 1 0.0002
432 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
433 HEPATIC ENZYME ABNORMAL 1 0.0002
434 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
435 THERAPY NON-RESPONDER 9 0.0002
436 LEUKOPENIA 10 0.0002
437 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
438 PRODUCT PHYSICAL ISSUE 4 0.0002
439 HYPOTHERMIA 2 0.0002
440 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
441 SEPSIS 22 0.0002
442 OEDEMA PERIPHERAL 24 0.0002
443 THERAPY INTERRUPTED 14 0.0002
444 PETIT MAL EPILEPSY 1 0.0002
445 ENDOCARDITIS 1 0.0002
446 DEVICE RELATED INFECTION 3 0.0002
447 CACHEXIA 1 0.0002
448 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
449 MALABSORPTION 1 0.0002
450 NEUTROPENIA 26 0.0002
451 PRODUCT ODOUR ABNORMAL 2 0.0002
452 PRODUCT USE COMPLAINT 3 0.0002
453 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
454 FULL BLOOD COUNT ABNORMAL 2 0.0002
455 SUDDEN DEATH 2 0.0002
456 ULCER 3 0.0002
457 CATARACT 11 0.0002
458 THERAPEUTIC RESPONSE DECREASED 11 0.0002
459 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
460 PLEURAL EFFUSION 11 0.0002
461 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
462 GASTRIC ULCER HAEMORRHAGE 1 0.0002
463 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
464 NECROSIS 1 0.0002
465 HAEMOPTYSIS 5 0.0002
466 CELLULITIS 9 0.0002
467 ACUTE PULMONARY OEDEMA 1 0.0002
468 SKIN TOXICITY 1 0.0002
469 MITRAL VALVE INCOMPETENCE 2 0.0002
470 INTENTIONAL DOSE OMISSION 5 0.0002
471 DERMATITIS CONTACT 2 0.0002
472 NEUROLOGICAL SYMPTOM 1 0.0002
473 CORONARY ARTERY BYPASS 1 0.0002
474 SKIN ATROPHY 1 0.0002
475 EXERCISE TOLERANCE DECREASED 1 0.0002
476 HERPES VIRUS INFECTION 1 0.0002
477 ENTEROCOLITIS 1 0.0002
478 BLOOD URIC ACID INCREASED 1 0.0002
479 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
480 NEOPLASM PROGRESSION 6 0.0002
481 SKIN WARM 1 0.0002
482 AMENORRHOEA 3 0.0002
483 BACTERAEMIA 2 0.0002
484 CATARACT OPERATION 1 0.0002
485 HEARING IMPAIRED 1 0.0002
486 RASH PRURITIC 9 0.0002
487 DERMATITIS ACNEIFORM 1 0.0002
488 PIGMENTATION DISORDER 1 0.0002
489 OLIGURIA 1 0.0002
490 BLOOD SODIUM DECREASED 3 0.0002
491 DERMATITIS ALLERGIC 2 0.0002
492 BLOOD URINE PRESENT 3 0.0002
493 GASTRIC ULCER 3 0.0002
494 HAEMATEMESIS 4 0.0002
495 CHOLESTASIS 3 0.0002
496 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
497 PROCTALGIA 1 0.0002
498 HAEMOGLOBIN ABNORMAL 1 0.0002
499 ANOREXIA 2 0.0002
500 HERNIA 3 0.0002
501 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
502 INCOHERENT 1 0.0002
503 HERPES SIMPLEX 1 0.0002
504 HAEMORRHOIDS 3 0.0002
505 NODULE 2 0.0002
506 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
507 BRADYPHRENIA 1 0.0002
508 SKIN IRRITATION 7 0.0002
509 SARS-COV-2 TEST POSITIVE 2 0.0002
510 HAEMATOCRIT DECREASED 3 0.0002
511 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
512 FEBRILE NEUTROPENIA 10 0.0002
513 CARDIAC FAILURE ACUTE 1 0.0001
514 QUALITY OF LIFE DECREASED 2 0.0001
515 PAIN OF SKIN 4 0.0001
516 METASTASES TO LYMPH NODES 1 0.0001
517 TASTE DISORDER 3 0.0001
518 PRODUCT TASTE ABNORMAL 2 0.0001
519 NEUTROPHIL COUNT DECREASED 6 0.0001
520 TREATMENT NONCOMPLIANCE 8 0.0001
521 INFARCTION 1 0.0001
522 ECCHYMOSIS 1 0.0001
523 APPLICATION SITE RASH 2 0.0001
524 INTERSTITIAL LUNG DISEASE 7 0.0001
525 ENCEPHALITIS 1 0.0001
526 MENTAL STATUS CHANGES 4 0.0001
527 PULMONARY HYPERTENSION 3 0.0001
528 LARGE INTESTINE PERFORATION 1 0.0001
529 DERMATITIS 3 0.0001
530 RIGHT VENTRICULAR FAILURE 1 0.0001
531 MOUTH ULCERATION 3 0.0001
532 BLOOD TEST ABNORMAL 2 0.0001
533 APPLICATION SITE REACTION 1 0.0001
534 DUODENAL ULCER 1 0.0001
535 PULMONARY TOXICITY 1 0.0001
536 DIALYSIS 2 0.0001
537 METASTASIS 1 0.0001
538 SUBDURAL HAEMATOMA 2 0.0001
539 POOR QUALITY SLEEP 3 0.0001
540 SKIN CANCER 3 0.0001
541 INTENTIONAL UNDERDOSE 1 0.0001
542 ORAL DISORDER 1 0.0001
543 ANAEMIA 26 0.0001
544 SENSITIVE SKIN 1 0.0001
545 PSYCHIATRIC SYMPTOM 1 0.0001
546 HYPOPHOSPHATAEMIA 1 0.0001
547 DEHYDRATION 18 0.0001
548 ARTHROPOD BITE 1 0.0001
549 NEOPLASM MALIGNANT 9 0.0001
550 PULMONARY MASS 2 0.0001
551 COLON CANCER 2 0.0001
552 PANCREATITIS ACUTE 3 0.0001
553 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
554 PAROSMIA 1 0.0001
555 PEMPHIGOID 1 0.0001
556 PRODUCT AVAILABILITY ISSUE 3 0.0001
557 AORTIC ANEURYSM 1 0.0001
558 HAEMODYNAMIC INSTABILITY 1 0.0001
559 ACIDOSIS 1 0.0001
560 BOWEL MOVEMENT IRREGULARITY 1 0.0001
561 SHOCK 3 0.0001
562 PERICARDIAL EFFUSION 3 0.0001
563 DELUSION 2 0.0001
564 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
565 CONDITION AGGRAVATED 39 0.0001
566 BASAL CELL CARCINOMA 2 0.0001
567 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
568 DISEASE RECURRENCE 6 0.0001
569 BLOOD ALBUMIN DECREASED 1 0.0001
570 RENAL CYST 1 0.0001
571 GINGIVAL PAIN 1 0.0001
572 ABSCESS 2 0.0001
573 PANCYTOPENIA 7 0.0001
574 BLOOD POTASSIUM INCREASED 2 0.0001
575 DECUBITUS ULCER 1 0.0001
576 PRURITUS 47 0.0001
577 ENCEPHALOPATHY 3 0.0001
578 OSTEONECROSIS 4 0.0001
579 ERYTHEMA 25 0.0001
580 ABASIA 3 0.0001
581 PHOTOSENSITIVITY REACTION 2 0.0001
582 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
583 MENSTRUAL DISORDER 1 0.0001
584 EMBOLISM 1 0.0001
585 SKIN DISORDER 4 0.0001
586 HAEMODIALYSIS 1 0.0001
587 CIRCULATORY COLLAPSE 2 0.0001
588 ERECTILE DYSFUNCTION 3 0.0001
589 HAEMATURIA 4 0.0001
590 PRODUCT CONTAINER ISSUE 1 0.0001
591 THROMBOCYTOPENIA 13 0.0001
592 MULTI-ORGAN FAILURE 2 0.0001
593 CARDIAC MURMUR 1 0.0001
594 ORTHOSTATIC HYPOTENSION 2 0.0001
595 DEAFNESS 3 0.0001
596 MUCOSAL INFLAMMATION 3 0.0001
597 NAIL DISORDER 1 0.0001
598 BLOOD CALCIUM INCREASED 1 0.0001
599 METASTASES TO LIVER 2 0.0001
600 HYPOXIA 4 0.0001
601 LYMPHOCYTE COUNT DECREASED 2 0.0001
602 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
603 ATRIAL FIBRILLATION 11 0.0001
604 LIVER DISORDER 5 0.0001
605 RESPIRATORY RATE INCREASED 1 0.0001
606 FACIAL PAIN 1 0.0001
607 MYALGIA 19 0.0001
608 HAEMOLYTIC ANAEMIA 1 0.0001
609 JAUNDICE 3 0.0001
610 INFECTION 16 0.0001
611 PNEUMONITIS 3 0.0001
612 EXOSTOSIS 1 0.0001
613 NEPHROLITHIASIS 5 0.0001
614 RETINAL DETACHMENT 1 0.0001
615 DYSURIA 4 0.0001
616 IRON DEFICIENCY ANAEMIA 1 0.0001
617 DIVERTICULITIS 3 0.0001
618 AGRANULOCYTOSIS 2 0.0001
619 WOUND 3 0.0001
620 BACTERIAL INFECTION 2 0.0001
621 DRUG INTERACTION 17 0.0001
622 COGNITIVE DISORDER 5 0.0001
623 DIARRHOEA HAEMORRHAGIC 1 0.0001
624 BLISTER 6 0.0001
625 OXYGEN SATURATION DECREASED 6 0.0001
626 ABORTION INDUCED 1 0.0001
627 LEUKAEMIA 1 0.0001
628 HYPOCALCAEMIA 2 0.0001
629 PNEUMONIA 34 0.0001
630 DRY SKIN 14 0.0001
631 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
632 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
633 ATELECTASIS 1 0.0001
634 LIVER FUNCTION TEST ABNORMAL 3 0.0001
635 EAR PAIN 2 0.0001
636 HEPATIC ENZYME INCREASED 7 0.0001
637 LUNG DISORDER 5 0.0001
638 BODY TEMPERATURE DECREASED 1 0.0001
639 LIGAMENT SPRAIN 1 0.0001
640 SALIVARY HYPERSECRETION 1 0.0001
641 PREGNANCY 2 0.0001
642 BRAIN INJURY 1 0.0001
643 HEPATIC FAILURE 3 0.0001
644 BONE MARROW FAILURE 2 0.0001
645 DRUG LEVEL DECREASED 1 0.0001
646 SUBARACHNOID HAEMORRHAGE 1 0.0001
647 SLUGGISHNESS 1 0.0001
648 BODY TEMPERATURE INCREASED 2 0.0001
649 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
650 PETECHIAE 1 0.0001
651 RENAL PAIN 1 0.0001
652 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
653 CHILLS 11 0.0001
654 LIVER FUNCTION TEST INCREASED 2 0.0001
655 NIGHT SWEATS 3 0.0001
656 CONFUSIONAL STATE 15 0.0001
657 PRURITUS GENERALISED 2 0.0001
658 FAECES DISCOLOURED 2 0.0001
659 OEDEMA 5 0.0001
660 CHRONIC KIDNEY DISEASE 7 0.0001
661 SKIN LACERATION 1 0.0001
662 PRODUCT DISPENSING ERROR 2 0.0001
663 PULMONARY THROMBOSIS 1 0.0001
664 ASPIRATION 1 0.0001
665 VISUAL ACUITY REDUCED 3 0.0001
666 FOOT DEFORMITY 1 0.0001
667 FUNGAL INFECTION 3 0.0001
668 STEVENS-JOHNSON SYNDROME 2 0.0001
669 RASH PAPULAR 2 0.0001
670 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
671 INTESTINAL PERFORATION 1 0.0001
672 OCULAR DISCOMFORT 1 0.0001
673 BLOOD CALCIUM DECREASED 1 0.0001
674 REBOUND EFFECT 1 0.0001
675 DEATH 76 0.0001
676 FLATULENCE 5 0.0001
677 OFF LABEL USE 77 0.0001
678 MYOCARDIAL ISCHAEMIA 1 0.0001
679 HAEMOGLOBIN DECREASED 9 0.0001
680 CHOLECYSTECTOMY 1 0.0001
681 TINNITUS 4 0.0001
682 SKIN DISCOLOURATION 4 0.0001
683 NEOPLASM 1 0.0001
684 LETHARGY 5 0.0001
685 GASTRIC HAEMORRHAGE 1 0.0001
686 METASTASES TO LUNG 1 0.0001
687 ELECTROLYTE IMBALANCE 1 0.0001
688 POST PROCEDURAL HAEMORRHAGE 1 0.0001
689 DRUG INEFFECTIVE 113 0.0001
690 SPLENOMEGALY 1 0.0001
691 SPINAL PAIN 1 0.0001
692 SEXUAL DYSFUNCTION 1 0.0001
693 DYSPHAGIA 8 0.0001
694 ATAXIA 1 0.0001
695 CHOLECYSTITIS 1 0.0001
696 MYOCLONUS 1 0.0001
697 RASH ERYTHEMATOUS 4 0.0001
698 POLYNEUROPATHY 1 0.0001
699 LOCALISED INFECTION 2 0.0001
700 CEREBRAL INFARCTION 2 0.0001
701 MUSCLE SPASTICITY 1 0.0001
702 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
703 GENERALISED OEDEMA 1 0.0001
704 CYST 1 0.0001
705 SECRETION DISCHARGE 1 0.0001
706 BRAIN OEDEMA 1 0.0001
707 WEIGHT DECREASED 22 0.0001
708 HEPATITIS 2 0.0001
709 PYREXIA 27 0.0001
710 DRUG RESISTANCE 2 0.0001
711 PLATELET COUNT INCREASED 1 0.0001
712 PRODUCT DOSE OMISSION 5 0.0001
713 BLOOD CREATININE INCREASED 5 0.0001
714 URINARY TRACT INFECTION 13 0.0001
715 ORAL CANDIDIASIS 1 0.0001
716 PULMONARY CONGESTION 1 0.0001
717 SOPOR 1 0.0001
718 EYE HAEMORRHAGE 1 0.0001
719 SWELLING 7 0.0001
720 JOINT RANGE OF MOTION DECREASED 1 0.0001
721 DRUG TOXICITY 1 0.0001
722 IMPAIRED GASTRIC EMPTYING 1 0.0001
723 GINGIVAL BLEEDING 1 0.0001
724 CARDIAC ARREST 6 0.0001
725 POLLAKIURIA 3 0.0001
726 DEMENTIA 2 0.0001
727 RENAL IMPAIRMENT 6 0.0001
728 HYPONATRAEMIA 4 0.0001
729 SEASONAL ALLERGY 1 0.0001
730 HYPOACUSIS 3 0.0001
731 HERPES ZOSTER 4 0.0001
732 PRODUCT SUBSTITUTION ISSUE 4 0.0001
733 PANCREATIC CARCINOMA 2 0.0001
734 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
735 MYELODYSPLASTIC SYNDROME 1 0.0001
736 DECREASED APPETITE 16 0.0001
737 CONSTIPATION 15 0.0001
738 RESPIRATORY FAILURE 5 0.0001
739 DYSSTASIA 2 0.0001
740 ACUTE MYOCARDIAL INFARCTION 2 0.0001
741 CARDIOMYOPATHY 1 0.0001
742 ABDOMINAL DISTENSION 7 0.0001
743 PULMONARY OEDEMA 3 0.0001
744 PRODUCT QUALITY ISSUE 9 0.0001
745 APHASIA 2 0.0001
746 BLOOD COUNT ABNORMAL 1 0.0001
747 OSTEOPENIA 1 0.0001
748 PLATELET COUNT DECREASED 7 0.0001
749 VERTIGO 4 0.0001
750 MUSCLE SPASMS 12 0.0001
751 HIP ARTHROPLASTY 1 0.0001
752 ADVERSE EVENT 6 0.0001
753 HOSPITALISATION 10 0.0001
754 MUSCULOSKELETAL CHEST PAIN 1 0.0001
755 FATIGUE 50 0.0001
756 ACUTE MYELOID LEUKAEMIA 1 0.0001
757 ASTHENIA 24 0.0001
758 PNEUMOTHORAX 1 0.0001
759 RESPIRATORY TRACT CONGESTION 1 0.0001
760 OBESITY 1 0.0001
761 HIP FRACTURE 2 0.0001
762 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
763 HYPOGLYCAEMIA 3 0.0001
764 METASTASES TO BONE 1 0.0001
765 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
766 RENAL FAILURE 8 0.0001
767 EXPIRED PRODUCT ADMINISTERED 2 0.0001
768 VIRAL INFECTION 2 0.0001
769 URINARY RETENTION 2 0.0001
770 RASH 26 0.0001
771 PERICARDITIS 1 0.0001
772 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
773 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
774 PRODUCT USE ISSUE 11 0.0001
775 SCAR 1 0.0001
776 GASTRIC DISORDER 2 0.0001
777 INFLAMMATION 3 0.0001
778 MUSCULOSKELETAL DISCOMFORT 1 0.0001
779 PARANOIA 1 0.0001
780 BALANCE DISORDER 5 0.0001
781 RASH MACULAR 2 0.0001
782 HEART RATE DECREASED 2 0.0001
783 COLD SWEAT 1 0.0001
784 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
785 TACHYCARDIA 5 0.0001
786 ISCHAEMIC STROKE 1 0.0001
787 CEREBRAL HAEMORRHAGE 2 0.0001
788 PELVIC PAIN 1 0.0001
789 C-REACTIVE PROTEIN INCREASED 2 0.0001
790 HYPERGLYCAEMIA 2 0.0001
791 BONE DISORDER 1 0.0001
792 PANIC ATTACK 2 0.0001
793 HAEMATOCHEZIA 3 0.0001
794 CONJUNCTIVITIS 1 0.0001
795 EYE SWELLING 2 0.0001
796 NECK PAIN 3 0.0001
797 EPISTAXIS 4 0.0001
798 CEREBROVASCULAR ACCIDENT 9 0.0001
799 INTESTINAL OBSTRUCTION 2 0.0001
800 PULMONARY EMBOLISM 5 0.0001
801 NEUROPATHY PERIPHERAL 5 0.0001
802 PULMONARY FIBROSIS 1 0.0001
803 ABDOMINAL PAIN 12 0.0001
804 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
805 CHOKING 1 0.0001
806 ORAL HERPES 1 0.0001
807 SURGERY 3 0.0001
808 KIDNEY INFECTION 1 0.0001
809 DISORIENTATION 2 0.0001
810 CARDIAC FAILURE CONGESTIVE 4 0.0000
811 DISCOMFORT 3 0.0000
812 FEELING HOT 3 0.0000
813 LUNG NEOPLASM MALIGNANT 2 0.0000
814 INFLUENZA LIKE ILLNESS 4 0.0000
815 PERITONITIS 1 0.0000
816 KNEE ARTHROPLASTY 1 0.0000
817 OSTEOARTHRITIS 2 0.0000
818 EATING DISORDER 1 0.0000
819 RETCHING 1 0.0000
820 NAUSEA 37 0.0000
821 RECTAL HAEMORRHAGE 2 0.0000
822 DEEP VEIN THROMBOSIS 3 0.0000
823 DYSPNOEA 26 0.0000
824 ALOPECIA 9 0.0000
825 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
826 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
827 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
828 PERIPHERAL SWELLING 7 0.0000
829 MELAENA 1 0.0000
830 BLOOD PRESSURE DECREASED 3 0.0000
831 HYPOTENSION 9 0.0000
832 ADVERSE DRUG REACTION 4 0.0000
833 HEART RATE IRREGULAR 1 0.0000
834 MEMORY IMPAIRMENT 6 0.0000
835 MUSCLE TWITCHING 1 0.0000
836 CHEST PAIN 8 0.0000
837 INJURY 3 0.0000
838 PAIN 26 0.0000
839 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
840 SKIN BURNING SENSATION 3 0.0000
841 ABDOMINAL DISCOMFORT 7 0.0000
842 HEADACHE 26 0.0000
843 PRESYNCOPE 1 0.0000
844 NEURALGIA 1 0.0000
845 HEART RATE INCREASED 4 0.0000
846 WEIGHT INCREASED 9 0.0000
847 AGEUSIA 1 0.0000
848 HALLUCINATION 3 0.0000
849 ABDOMINAL PAIN LOWER 1 0.0000
850 FLUSHING 4 0.0000
851 ACUTE KIDNEY INJURY 6 0.0000
852 HYPOPHAGIA 1 0.0000
853 FALL 13 0.0000
854 ABDOMINAL PAIN UPPER 8 0.0000
855 ANAPHYLACTIC SHOCK 1 0.0000
856 HAEMATOMA 1 0.0000
857 DIPLOPIA 1 0.0000
858 RESPIRATORY TRACT INFECTION 1 0.0000
859 SPEECH DISORDER 2 0.0000
860 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
861 DERMATITIS ATOPIC 2 0.0000
862 PANCREATITIS 2 0.0000
863 DEPRESSED MOOD 2 0.0000
864 BLOOD GLUCOSE INCREASED 7 0.0000
865 FREQUENT BOWEL MOVEMENTS 1 0.0000
866 BLOOD BILIRUBIN INCREASED 1 0.0000
867 DRY MOUTH 3 0.0000
868 LIMB INJURY 1 0.0000
869 DRUG DOSE OMISSION 6 0.0000
870 RESPIRATORY DISTRESS 1 0.0000
871 ABNORMAL DREAMS 1 0.0000
872 VOMITING 17 0.0000
873 DIZZINESS 18 0.0000
874 FEELING COLD 1 0.0000
875 TOXICITY TO VARIOUS AGENTS 6 0.0000
876 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
877 RED BLOOD CELL COUNT DECREASED 1 0.0000
878 HYPERSOMNIA 1 0.0000
879 BACK PAIN 8 0.0000
880 MYOCARDIAL INFARCTION 6 0.0000
881 DYSPHONIA 2 0.0000
882 ASCITES 1 0.0000
883 LABORATORY TEST ABNORMAL 1 0.0000
884 FEELING ABNORMAL 8 0.0000
885 BLOOD POTASSIUM DECREASED 1 0.0000
886 SUICIDE ATTEMPT 2 0.0000
887 EPILEPSY 1 0.0000
888 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
889 NASOPHARYNGITIS 6 0.0000
890 OROPHARYNGEAL PAIN 3 0.0000
891 FEMUR FRACTURE 1 0.0000
892 EXPOSURE DURING PREGNANCY 2 0.0000
893 COUGH 9 0.0000
894 DRUG-INDUCED LIVER INJURY 1 0.0000
895 HEAD INJURY 1 0.0000
896 CYSTITIS 1 0.0000
897 ARTHRALGIA 13 0.0000
898 DIARRHOEA 20 0.0000
899 LACTIC ACIDOSIS 1 0.0000
900 DEPRESSION 7 0.0000
901 SWELLING FACE 2 0.0000
902 DYSPEPSIA 3 0.0000
903 INFUSION RELATED REACTION 2 0.0000
904 LIP SWELLING 1 0.0000
905 SYNCOPE 3 0.0000
906 EYE PRURITUS 1 0.0000
907 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
908 CHEST DISCOMFORT 3 0.0000
909 VISION BLURRED 4 0.0000
910 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
911 DELIRIUM 1 0.0000
912 HYPERKALAEMIA 1 0.0000
913 COVID-19 5 0.0000
914 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
915 DRUG EFFECT INCOMPLETE 1 0.0000
916 ACCIDENTAL OVERDOSE 1 0.0000
917 AGITATION 2 0.0000
918 BRONCHITIS 2 0.0000
919 HYPERSENSITIVITY 5 0.0000
920 DYSGEUSIA 2 0.0000
921 MUSCULAR WEAKNESS 3 0.0000
922 COLITIS 1 0.0000
923 ACNE 2 0.0000
924 DIABETES MELLITUS 2 0.0000
925 PLASMA CELL MYELOMA 1 0.0000
926 ANXIETY 7 0.0000
927 TREMOR 4 0.0000
928 ROAD TRAFFIC ACCIDENT 1 0.0000
929 URTICARIA 4 0.0000
930 HYPERHIDROSIS 3 0.0000
931 INTENTIONAL PRODUCT MISUSE 2 0.0000
932 MALAISE 10 0.0000
933 INSOMNIA 6 0.0000
934 COLITIS ULCERATIVE 1 0.0000
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
936 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
937 INCORRECT DOSE ADMINISTERED 5 0.0000
938 HYPOKALAEMIA 1 0.0000
939 RENAL DISORDER 1 0.0000
940 ARRHYTHMIA 1 0.0000
941 COMA 1 0.0000
942 RENAL CANCER 1 0.0000
943 PRODUCTIVE COUGH 1 0.0000
944 GAIT DISTURBANCE 4 0.0000
945 BLOOD GLUCOSE DECREASED 1 0.0000
946 CONTUSION 2 0.0000
947 DRY EYE 1 0.0000
948 AGGRESSION 1 0.0000
949 FLUID RETENTION 1 0.0000
950 BLOOD PRESSURE INCREASED 3 0.0000
951 SINUSITIS 2 0.0000
952 ILLNESS 2 0.0000
953 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
954 HAEMORRHAGE 2 0.0000
955 MUSCULOSKELETAL PAIN 1 0.0000
956 DRUG EFFECT DECREASED 1 0.0000
957 DISTURBANCE IN ATTENTION 1 0.0000
958 MEDICATION ERROR 1 0.0000
959 INFLUENZA 2 0.0000
960 CONVULSION 1 0.0000
961 SEIZURE 2 0.0000
962 NASAL CONGESTION 1 0.0000
963 IRRITABILITY 1 0.0000
964 JOINT SWELLING 2 0.0000
965 EMOTIONAL DISTRESS 2 0.0000
966 STOMATITIS 1 0.0000
967 ILL-DEFINED DISORDER 1 0.0000
968 VISUAL IMPAIRMENT 2 0.0000
969 LOSS OF CONSCIOUSNESS 2 0.0000
970 RHINORRHOEA 1 0.0000
971 AMNESIA 1 0.0000
972 SOMNOLENCE 3 0.0000
973 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
974 BURNING SENSATION 1 0.0000
975 HYPERTENSION 3 0.0000
976 MOBILITY DECREASED 1 0.0000
977 PAIN IN EXTREMITY 4 0.0000
978 HYPOAESTHESIA 2 0.0000
979 HOT FLUSH 1 0.0000
980 ARTHRITIS 1 0.0000
981 PROSTATE CANCER 1 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
983 MUSCULOSKELETAL STIFFNESS 1 0.0000
984 GASTROINTESTINAL DISORDER 1 0.0000
985 NO ADVERSE EVENT 2 0.0000
986 BREAST CANCER 1 0.0000
987 CARDIAC DISORDER 1 0.0000
988 DRUG INTOLERANCE 1 0.0000
989 PALPITATIONS 1 0.0000
990 PSORIASIS 1 0.0000
991 OVERDOSE 1 0.0000
992 INJECTION SITE PAIN 1 0.0000